# Immunome, Inc. (IMNM)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/IMNM/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -126.97M | $ -125.51M | $ 4.59M | $ 525.08M |
| 2025 | $ 7.11M | $ -217.47M | $ -205.40M | $ 3.86M | $ 634.34M |
| 2024 | $ 9.50M | $ -307.93M | $ -124.25M | $ 4.83M | $ 181.17M |
| 2023 | $ 15.16M | $ -115.48M | $ -9.08M | $ 1.65M | $ 119.88M |
| 2022 | $ 0 | $ -41.22M | $ -32.33M | $ 291.0K | $ 16.65M |
| 2021 | $ 0 | $ -29.37M | $ -21.76M | $ 317.0K | $ 48.19M |
| 2020 | $ 0 | $ -22.72M | $ -16.20M | $ 613.0K | $ 41.35M |
| 2019 | $ 0 | $ -13.48M | $ -12.69M | $ 564.0K | $ -35.63M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.01 |
| Liabilities / Eq | 0.08 |
| Current Ratio | 15.08 |

## Other views

- [Metrics](https://sponda.capital/en/IMNM.md)
- [Charts](https://sponda.capital/en/IMNM/charts.md)
- [Compare](https://sponda.capital/en/IMNM/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.